The goal to achieve the first milestone has succeeded; Target molecule validated and the first proof-of-principle in muscle tissue completed.
Download a pdf of the Pressrelease
Promising Results in Treatment with GLX
US Patent Received for Diabetes Treatment
Glucox' Unique Research Discovery Confirmed by US Scientist
Patent Application Submitted for the GLX Compounds
A Significant Preclinical Milestone Achieved
Positive Results from the First Time In Animal Study
Changes in Board of Directors
Evaluation and Selection of Glucox Biotech' Lead Drug Candidates
First Milestone Succeeded.